Factors associated with rapid improvement in visual acuity in patients with Leber's hereditary optic neuropathy after gene therapy

Abstract

The period between onset and treatment, and pretreatment baseline BCVA may be important predictors of rapid and significant improvement in visual acuity in patients with LHON after gene therapy.